MGUS   

Risk factors include: non-IgG subtype, abnormal serum light chain ratio, M-protein >=1.5 mg/dL. Further work up could include imaging, bone marrow...

New data suggests monoclonal gammopathies can be associated with thrombotic events. Is your practice changing to include monoclonal gammopathy evaluat...

When would you consider a bone marrow biopsy?

Does it assist in prognosis in any way?

Infection is not part of the criteria for starting treatment both in UpToDate and in NCCN guidelines. 

What if the patient is no longer responding to steroids?

If so, what is your approach to laboratory and clinical testing?